FT
Flare TherapeuticsFlare Therapeutics is a clinical-stage biotech developing small-molecule drugs that target transcription factors, including a first-in-class ARON-targeting degrader for prostate cancer.
2 Pulse stories
TM
Tenon MedicalTenon Medical develops the Catamaran, a minimally invasive titanium implant system for sacroiliac joint fusion to treat lower back pain.
1 Pulse story
Total Raised
$290M
Flare TherapeuticsTenon Medical
Last ValuationNot disclosed
Biotech
Sector
Biotech
2021
Founded
2012
Cambridge, Massachusetts
HQ
Los Gatos, California
Private
Status
Public (TNON)
Flare Therapeutics investors
Third Rock VenturesNextech InvestPfizer VenturesBoxer CapitalGordonMD Global InvestmentsInvusCasdin CapitalEli Lilly and Company
Tenon Medical investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for Flare Therapeutics and Tenon Medical.